Evaluation for the Presence of SARS-CoV-2 in CO(2) Laser Plume

评估二氧化碳激光羽流中是否存在SARS-CoV-2

阅读:1

Abstract

ImportanceSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly infectious virus that has been reported to be transmitted via aerosolization and other aerosol-generating activities. However, viral plumes from CO(2) lasers have yet to be investigated.ObjectiveEvaluate the viability of SARS-CoV-2 in the CO(2) laser plume in a porcine model for laryngeal surgery.DesignExperimental studies.SettingLaboratory.ParticipantsWild-type SARS-CoV-2 (Wt), Omicron SARS-CoV-2 (Omicron), and fluorescent SARS-CoV-2 (GFP).InterventionThree viral strains on porcine larynx exposed to CO(2) laser setting-1.5, 7, and 15 W.Main Outcome MeasuresThe laser plume was collected during ablation. Dilutant of the plume was then applied to Vero E6 cells for culture; quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) (in duplicate) and fluoroscopy were used to establish the presence of viable virus.ResultsWt, Omicron, and GFP strains were found to be present on the larynx before and after the application of the laser by qPCR copies (cp) per microliter (µl). After ablation with 1.5, 7.0, and 15 W with Wt, the plume samples were shown to be 0, 0, and <10 cp/µl, respectively. For GFP, at all intensity levels, the copies were less than 10 cp/µl. Omicron did not show any copies at any of the power levels. Cultures did not show the presence of viable Wt, Omicron, and GFP strains in any of the collected laser plumes.ConclusionThe CO(2) laser plume of SARS-CoV-2 aerosolized minimal viral particles. None of the tested experimental conditions demonstrated a viable virus after laryngeal ablation with the CO(2) laser.RelevanceCO(2) laser use in the context of virus SARS-CoV-2 suggests minimal transmission risks associated with CO(2) laser procedures when appropriate safety protocols are followed.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。